�����ƽ��

Canadian-based biotech company adopts internationally recognized standards to enhance environmental performance

Vancouver, BC, June 23, 2022 – �����ƽ�� Technologies, Canada’s largest biotechnology company, announced today that it has received ISO 14001:2015 certification of its Environmental Management System at its Canadian operations in Vancouver, BC.

�����ƽ��’s now-certified Environmental Management System will enable the company to monitor, measure, analyze, and evaluate its environmental performance.

“As global citizens, all of us at �����ƽ�� understand we have an important role to play in addressing climate change and protecting the planet to help create a better, healthier future for everyone,” said Dr. Allen Eaves, �����ƽ��’s President and CEO. “With this ISO 14001 certification, our customers and communities can have complete confidence that we are operating in accordance with best environmental management practices when creating and offering our best-in-class products and services for scientific research.”

The ISO 14001 certification—which applies to �����ƽ��’s manufacturing, shipping, research and development, and head office facilities—is voluntary and confirms �����ƽ��’s shared commitment to environmental stewardship through improving processes and procedures to reduce waste and lower carbon output.

The evaluation and audit of �����ƽ��’s Environmental Management System was independently conducted by DEKRA, an internationally recognized authority that assesses environmental management systems for ISO 14001 certification.

“This achievement is only the beginning,” said Dr. Eaves.“We will build upon this momentum to go even further to embed sustainability practices into every aspect of our business and continue to improve our environmental performance now and into the future.”

More information about the International Organization for Standardization (ISO) can be found by visiting .

About �����ƽ�� Technologies
supports life sciences research with more than 2,500 specialized reagents, tools, and services. �����ƽ�� offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

For more information and to arrange an interview, contact Kim Nelson, Director, Communications and Corporate Social Responsibility, �����ƽ�� Technologies: public.relations@stemcell.com